Exploring subcortical pathology and processing speed in neuromyelitis optica spectrum disorder with myelin water imaging.
Autor: | Tsai CC; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Combes A; Department of Neuroinflammation, NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London, London, UK., McMullen K; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Kolind SH; the Division of Neurology, Department of Medicine and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada., Traboulsee AL; the Division of Neurology, Department of Medicine and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of neuroimaging : official journal of the American Society of Neuroimaging [J Neuroimaging] 2025 Jan-Feb; Vol. 35 (1), pp. e13250. Date of Electronic Publication: 2024 Nov 07. |
DOI: | 10.1111/jon.13250 |
Abstrakt: | Background and Purpose: Neuromyelitis optica spectrum disorder (NMOSD) affects the optic nerves and spinal cord but can also cause focal brain inflammation. Subcortical pathology may contribute to the etiology of cognitive deficits in NMOSD. Using myelin water imaging, we investigated cerebral normal-appearing white matter (NAWM) and thalamic metrics and their association with cognition in NMOSD participants compared to healthy controls (HC). Methods: Seventeen NMOSD participants and 21 HC were scanned on a 3.0-Tesla MRI scanner using a multicomponent driven-equilibrium single-pulse observation of T Results: Compared to HC, NMOSD participants had reduced white matter volume (-14.2%, p < .0001), increased T Conclusions: NAWM in NMOSD demonstrates diffuse abnormalities with increased water content and demyelination, suggesting a diffuse disease process overlooked by focal inflammation measures. Increased water content, as a biomarker for diffuse thalamic pathology, may partially explain cognitive impairment in NMOSD. (© 2024 The Author(s). Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging.) |
Databáze: | MEDLINE |
Externí odkaz: |